Advancing siRNA Therapeutics with Pharmacometrics: A Review of Modeling Approaches and Clinical Applications.
This review examines how model-informed drug development, particularly pharmacometric modeling, has emerged as an essential tool in the advancement of siRNA therapeutics and how quantitative pharmacology addresses developmental challenges, including first-in-human dose selection, optimal dosing intervals, organ impairment effects, and interindividual variability.